364 related articles for article (PubMed ID: 24576272)
1. Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy.
Prince DS; McGuigan LE; McGirr EE
Int J Rheum Dis; 2014 Feb; 17(2):165-72. PubMed ID: 24576272
[TBL] [Abstract][Full Text] [Related]
2. Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitis.
Keat AC; Gaffney K; Gilbert AK; Harris C; Leeder J
Rheumatology (Oxford); 2008 Apr; 47(4):481-3. PubMed ID: 18281690
[TBL] [Abstract][Full Text] [Related]
3. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.
Pham T; Landewé R; van der Linden S; Dougados M; Sieper J; Braun J; Davis J; Rudwaleit M; Collantes E; Burgos-Vargas R; Edmonds J; Olivieri I; van der Horst-Bruinsma I; Mielants H; Stone M; Emery P; van der Heijde D
Ann Rheum Dis; 2006 Dec; 65(12):1620-5. PubMed ID: 16464984
[TBL] [Abstract][Full Text] [Related]
4. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
[TBL] [Abstract][Full Text] [Related]
5. Dosage adjustment of anti-tumor necrosis factor-α inhibitor in ankylosing spondylitis is effective in maintaining remission in clinical practice.
Paccou J; Baclé-Boutry MA; Solau-Gervais E; Bele-Philippe P; Flipo RM
J Rheumatol; 2012 Jul; 39(7):1418-23. PubMed ID: 22707611
[TBL] [Abstract][Full Text] [Related]
6. Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis.
Maksymowych WP; Gooch KL; Wong RL; Kupper H; van der Heijde D
J Rheumatol; 2010 Feb; 37(2):385-92. PubMed ID: 19955052
[TBL] [Abstract][Full Text] [Related]
7. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.
Braun J; Davis J; Dougados M; Sieper J; van der Linden S; van der Heijde D;
Ann Rheum Dis; 2006 Mar; 65(3):316-20. PubMed ID: 16096329
[TBL] [Abstract][Full Text] [Related]
8. 'It's magic stuff': the experiences of patients with ankylosing spondylitis taking anti-TNF-alpha medication.
Stockdale J; Goodacre L
Musculoskeletal Care; 2009 Sep; 7(3):162-77. PubMed ID: 19065621
[TBL] [Abstract][Full Text] [Related]
9. What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical function.
van Weely SF; van Denderen JC; Steultjens MP; Nurmohamed MT; Dijkmans BA; Dekker J; van der Horst-Bruinsma IE
Rheumatology (Oxford); 2013 Oct; 52(10):1884-9. PubMed ID: 23864170
[TBL] [Abstract][Full Text] [Related]
10. Understanding limitations in at-work productivity in patients with active ankylosing spondylitis: the role of work-related contextual factors.
Boonen A; Boone C; Albert A; Mielants H
J Rheumatol; 2015 Jan; 42(1):93-100. PubMed ID: 25362661
[TBL] [Abstract][Full Text] [Related]
11. Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis.
Sağ S; Nas K; Sağ MS; Tekeoğlu İ; Kamanlı A
J Back Musculoskelet Rehabil; 2018; 31(3):499-505. PubMed ID: 29504521
[TBL] [Abstract][Full Text] [Related]
12. Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.
Kristensen LE; Petersson IF; Geborek P; Jöud A; Saxne T; Jacobsson LT; Englund M
Rheumatology (Oxford); 2012 Feb; 51(2):243-9. PubMed ID: 21565900
[TBL] [Abstract][Full Text] [Related]
13. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.
Song IH; Heldmann F; Rudwaleit M; Listing J; Appel H; Braun J; Sieper J
Arthritis Rheum; 2010 May; 62(5):1290-7. PubMed ID: 20461780
[TBL] [Abstract][Full Text] [Related]
14. Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index in Turkish patients with ankylosing spondylitis: relationship with disease activity and quality of life.
Zahiroglu Y; Ulus Y; Akyol Y; Tander B; Durmus D; Bilgici A; Kuru O
Int J Rheum Dis; 2014 Feb; 17(2):173-80. PubMed ID: 24576273
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of sleep quality in patients with ankylosing spondylitis and efficacy of anti-TNF-α therapy on sleep problems: A polisomnographic study.
Karatas G; Bal A; Yuceege M; Firat H; Gurcay E; Ardic S; Cakci FA
Int J Rheum Dis; 2018 Jun; 21(6):1263-1269. PubMed ID: 28556500
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
[TBL] [Abstract][Full Text] [Related]
17. Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practice.
Arends S; van der Veer E; Kamps FB; Houtman PM; Bos R; Bootsma H; Brouwer E; Spoorenberg A
Clin Exp Rheumatol; 2015; 33(2):174-80. PubMed ID: 25797228
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.
Song IH; Rudwaleit M; Listing J; Sieper J
Ann Rheum Dis; 2009 Nov; 68(11):1701-7. PubMed ID: 19029168
[TBL] [Abstract][Full Text] [Related]
19. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
Braun J; Baraliakos X; Listing J; Fritz C; Alten R; Burmester G; Krause A; Schewe S; Schneider M; Sörensen H; Zeidler H; Sieper J
Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831
[TBL] [Abstract][Full Text] [Related]
20. Infliximab in severe active ankylosing spondylitis with spinal ankylosis.
Cheung PP; Tymms KE; Wilson BJ; Shadbolt B; Brook AS; Dorai Raj AK; Khoo KB
Intern Med J; 2008 Jun; 38(6):396-401. PubMed ID: 18336538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
